301108.SZ
Tongling Jieya Biologic Technology Co., Ltd.
SZSE · C 制造业 · CN
CNY 46.97
−0.45%Margins
Gross margin
26.2%
EBITDA margin
15.7%
EBIT margin
10.3%
Net margin
9.2%
FCF margin
-24.2%
4.1%
Return on equity
3.2%
Return on assets
4.4%
Return on invested capital
0.36x
Asset turnover
CNY 124.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026